Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advate vs Recombinate PK in Severe Hemophilia A
NCT00666406Phase 4Completed
- Sponsor
- Takeda
- Start
- Mar 2008
- Primary completion
- Feb 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Mar 2008; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00666406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666406.